Miglitol is used in the treatment of type 2 diabetes mellitus which is also known as non-insulin-dependent diabetes (NIDDM).
How it Works
Miglitol functions to stop the occurrence of PPHG (postprandial hyperglycemia), which is also known as high blood sugar after food consumption. The active ingredient in Miglitol is a an oral alpha glucosidase inhibitor derived from desoxynojirimycin. When administered orally, Miglitol causes a reduction in the amount of sugar absorbed into the blood after you eat a meal. However, Miglitol's effect is not due to stimulating the release of insulin. Instead, carbohydrates are prevented from being digested into monosaccharides (a form of sugar that can be easily absorbed into the blood), thereby preventing a rise in blood sugar after eating.
Common Side effects
Patients who take Miglitol may suffer from such side effects; Gas, Pain occurring in the stomach, Passing stools which are loose, Mild symptoms affecting the skin, Gastrointestinal reactions causing pain, Skin rash, Flatulence, Abdominal pain, Diarrhoea